Literature DB >> 25209710

Systemic inflammation in xenograft recipients precedes activation of coagulation.

Mohamed B Ezzelarab1, Burcin Ekser, Agnes Azimzadeh, Chih Che Lin, Yuming Zhao, Rachael Rodriguez, Gabriel J Echeverri, Hayato Iwase, Cassandra Long, Hidetaka Hara, David Ayares, Richard N Pierson, Angus W Thomson, David K Cooper.   

Abstract

BACKGROUND: Dysregulation of coagulation is considered a major barrier against successful pig organ xenotransplantation in non-human primates. Inflammation is known to promote activation of coagulation. The role of pro-inflammatory factors as well as the relationship between inflammation and activation of coagulation in xenograft recipients is poorly understood.
METHODS: Baboons received kidney (n=3), heart (n=4), or artery patch (n=8) xenografts from α1,3-galactosyltransferase gene-knockout (GTKO) pigs or GTKO pigs additionally transgenic for human complement-regulatory protein CD46 (GTKO/CD46). Immunosuppression (IS) was based on either CTLA4Ig or anti-CD154 costimulation blockade. Three artery patch recipients did not receive IS. Pro-inflammatory cytokines, chemokines, and coagulation parameters were evaluated in the circulation after transplantation. In artery patch recipients, monocytes and dendritic cells (DC) were monitored in peripheral blood. Expression of tissue factor (TF) and CD40 on monocytes and DC were assessed by flow cytometry. C-reactive protein (C-RP) levels in the blood and C-RP deposition in xenografts as well as native organs were evaluated. Baboon and pig C-RP mRNA in heart and kidney xenografts were evaluated.
RESULTS: In heart and kidney xenograft recipients, the levels of INFγ, TNF-α, IL-12, and IL-8 were not significantly higher after transplantation. However, MCP-1 and IL-6 levels were significantly higher after transplantation, particularly in kidney recipients. Elevated C-RP levels preceded activation of coagulation in heart and kidney recipients, where high levels of C-RP were maintained until the time of euthanasia in both heart and kidney recipients. In artery patch recipients, INFγ, TNF-α, IL-12, IL-8, and MCP-1 were elevated with no IS, while IL-6 was not. With IS, INFγ, TNF-α, IL-12, IL-8, and MCP-1 were reduced, but IL-6 was elevated. Elevated IL-6 levels were observed as early as 2 weeks in artery patch recipients. While IS was associated with reduced thrombin activation, fibrinogen and C-RP levels were increased when IS was given. There was a significant positive correlation between C-RP, IL-6, and fibrinogen levels. Additionally, absolute numbers of monocytes were significantly increased when IS was given, but not without IS. This was associated with increased CD40 and TF expression on CD14+ monocytes and lineage(neg) CD11c+ DC, with increased differentiation of the pro-inflammatory CD14+ CD11c+ monocyte population. At the time of euthanasia, C-RP deposition in kidney and heart xenografts, C-RP positive cells in artery patch xenograft and native lungs were detected. Finally, high levels of both pig and baboon C-RP mRNA were detected in heart and kidney xenografts.
CONCLUSIONS: Inflammatory responses precede activation of coagulation after organ xenotransplantation. Early upregulation of C-RP and IL-6 levels may amplify activation of coagulation through upregulation of TF on innate immune cells. Prevention of systemic inflammation in xenograft recipients (SIXR) may be required to prevent dysregulation of coagulation and avoid excessive IS after xenotransplantation.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-reactive protein; coagulation; dendritic cells; inflammation; interleukin-6; monocytes; pig; primate; xenotransplantation

Mesh:

Substances:

Year:  2014        PMID: 25209710      PMCID: PMC4329078          DOI: 10.1111/xen.12133

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  65 in total

1.  Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.

Authors:  Christoph Bickel; Hans J Rupprecht; Stefan Blankenberg; Christine Espiniola-Klein; Axel Schlitt; Gerd Rippin; Gerd Hafner; Rainer Treude; Hisham Othman; Klaus-Peter Hofmann; Jürgen Meyer
Journal:  Am J Cardiol       Date:  2002-04-15       Impact factor: 2.778

2.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.

Authors:  E K Kruithof; J C Mestries; M P Gascon; A Ythier
Journal:  Thromb Haemost       Date:  1997-05       Impact factor: 5.249

4.  Serum C-reactive protein in pediatric kidney and liver transplant patients.

Authors:  Maria Their; Kai Rönnholm; Heikki Sairanen; Christer Holmberg; Hannu Jalanko
Journal:  Pediatr Transplant       Date:  2002-04

5.  Human alveolar macrophage and blood monocyte interleukin-6 production.

Authors:  R M Kotloff; J Little; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  1990-11       Impact factor: 6.914

Review 6.  Controlling coagulation dysregulation in xenotransplantation.

Authors:  Peter J Cowan; Simon C Robson; Anthony J F d'Apice
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

7.  Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis.

Authors:  A Baidoshvili; R Nijmeijer; W K Lagrand; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

8.  Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates.

Authors:  Mohamed B Ezzelarab; Burcin Ekser; Gabriel Echeverri; Hidetaka Hara; Corin Ezzelarab; Cassandra Long; Pietro Bajona; Bertha Garcia; Noriko Murase; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

9.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

10.  Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

Authors:  Paolo Calabró; James T Willerson; Edward T H Yeh
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

View more
  35 in total

1.  Stroke therapy: the potential of amniotic fluid-derived stem cells.

Authors:  Maya Elias; Jaclyn Hoover; Hung Nguyen; Stephanny Reyes; Christopher Lawton; Cesar V Borlongan
Journal:  Future Neurol       Date:  2015

2.  An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.

Authors:  Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

3.  Further evidence for sustained systemic inflammation in xenograft recipients (SIXR).

Authors:  Hayato Iwase; Burcin Ekser; Huidong Zhou; Hong Liu; Vikas Satyananda; Rishab Humar; Pooja Humar; Hidetaka Hara; Cassandra Long; Jay K Bhama; Pietro Bajona; Yi Wang; Martin Wijkstrom; David Ayares; Mohamed B Ezzelarab; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-08-21       Impact factor: 3.907

4.  B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Authors:  Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase
Journal:  Transpl Immunol       Date:  2018-08-06       Impact factor: 1.708

5.  Interleukin-8 mediates neutrophil-endothelial interactions in pig-to-human xenogeneic models.

Authors:  Beth M French; Selin Sendil; Krishna Mohan Sepuru; Jolene Ranek; Lars Burdorf; Donald Harris; Emily Redding; Xiangfei Cheng; Christopher T Laird; Yuming Zhao; Benjamin Cerel; Krishna Rajarathnam; Richard N Pierson; Agnes M Azimzadeh
Journal:  Xenotransplantation       Date:  2018-02-09       Impact factor: 3.907

6.  Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers.

Authors:  James Russell Butler; Leela L Paris; Ross L Blankenship; Richard A Sidner; Gregory R Martens; Joseph M Ladowski; Ping Li; Jose L Estrada; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

Review 7.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

8.  Delayed revascularization of islets after transplantation by IL-6 blockade in pig to non-human primate islet xenotransplantation model.

Authors:  Byoung-Hoon Min; Jun-Seop Shin; Jong-Min Kim; Seong-Jun Kang; Hyun-Je Kim; Il-Hee Yoon; Su-Kyoung Park; Ji-Won Choi; Min-Suk Lee; Chung-Gyu Park
Journal:  Xenotransplantation       Date:  2017-12-06       Impact factor: 3.907

Review 9.  Xenotransplantation: past, present, and future.

Authors:  Burcin Ekser; Ping Li; David K C Cooper
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

Review 10.  Immunobiological barriers to xenotransplantation.

Authors:  David K C Cooper; Burcin Ekser; A Joseph Tector
Journal:  Int J Surg       Date:  2015-07-06       Impact factor: 6.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.